Alphapointe CEO Reinhard Maybry said his company developed a superior new battlefield tourniquet, but the competitor holding the contract isn’t playing fair as the U.S. Army decides which one to use.
Alphapointe CEO Reinhard Maybry said his company developed a superior new battlefield tourniquet, but the competitor holding the contract isn’t playing fair as the U.S. Army decides which one to use.